AstraZeneca to sell anti-psychotic medicine rights in Europe and Russia for $239m

AstraZeneca to sell anti-psychotic medicine rights in Europe and Russia for $239m

Submitted by admin on October 31, 2019 - 10:14am
Source: 
Pharmaceutical Business Review
News Tags: 
AstraZeneca
Seroquel
antipsychotic
Europe
Russia
Cheplapharm
Headline: 
AstraZeneca to sell anti-psychotic medicine rights in Europe and Russia for $239m
snippet: 

AstraZeneca has signed an agreement to sell Seroquel medicine rights in Europe and Russia to Cheplapharm Arzneimittel for around $239m.

Do Not Allow Advertisers to Use My Personal information